Anika Therapeutics | Pasivo Circulante



Current Liabilities Cambio Fecha
Abbott USD 13B 1.15B 2025-03
Agios Pharmaceuticals USD 52.37M 28.79M 2025-03
Arrowhead Research USD 220.54M 126.78M 2025-03
Halozyme Therapeutics USD 150.38M 11.28M 2025-03
Insmed USD 239.23M 58.29M 2025-03
Integra LifeSciences USD 918.45M 3.67M 2025-03
J&J USD 56.9B 6.58B 2025-03
Ligand Pharmaceuticals USD 58.68M 21.57M 2025-03
MacroGenics USD 55.53M 3.78M 2024-12
Merit Medical Systems USD 196.82M 19.58M 2025-03
Sanofi 32.22B 3.06B 2025-03
Smith & Nephew USD 1.53B 246M 2024-12
Stryker USD 7.93B 313M 2025-03
Veracyte USD 75.12M 3.51M 2025-03
Xencor USD 88.44M 1M 2025-03
Zimmer Biomet Holdings USD 2.45B 1.12B 2024-12



Anika Therapeutics Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Jul 2025.